Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics
Philip Homan, Joon-Yong Chung, Woonghee Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 27, 2022
Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants
Jessica Hong, Hyung Joon Kwon, Raul Cachau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PET
Stanley Fayn, Woonghee Lee, Falguni Basuli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2023
Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy
Rosa Nguyen, Ekaterina Doubrovina, Charlotte M Mousset, et al.
Cell Reports. Medicine
|
July 1, 2021
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
Nan Li, Madeline B Torres, Madeline R Spetz, et al.
Cell Reports. Medicine
|
April 30, 2026
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy
Pradip Bajgain, Yang Feng, Mariela Puebla, et al.
Bioconjugate Chemistry
|
March 10, 2007
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice
David Filpula, Karen Yang, Amartya Basu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 3, 2026
Development of novel GPC2-directed radiotheranostics and CAR T-cell therapy for neuroblastoma
Ira Phadke, Divya Nambiar, George Diehl, et al.
The Journal of Clinical Investigation
|
July 19, 2022
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma
Meijie Tian, Adam T Cheuk, Jun S Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses
Daniel H Sterman, Adri Recio, Richard G Carroll, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics
Philip Homan, Joon-Yong Chung, Woonghee Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 27, 2022
Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants
Jessica Hong, Hyung Joon Kwon, Raul Cachau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PET
Stanley Fayn, Woonghee Lee, Falguni Basuli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2023
Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy
Rosa Nguyen, Ekaterina Doubrovina, Charlotte M Mousset, et al.
Cell Reports. Medicine
|
July 1, 2021
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
Nan Li, Madeline B Torres, Madeline R Spetz, et al.
Cell Reports. Medicine
|
April 30, 2026
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy
Pradip Bajgain, Yang Feng, Mariela Puebla, et al.
Bioconjugate Chemistry
|
March 10, 2007
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice
David Filpula, Karen Yang, Amartya Basu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 3, 2026
Development of novel GPC2-directed radiotheranostics and CAR T-cell therapy for neuroblastoma
Ira Phadke, Divya Nambiar, George Diehl, et al.
The Journal of Clinical Investigation
|
July 19, 2022
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma
Meijie Tian, Adam T Cheuk, Jun S Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses
Daniel H Sterman, Adri Recio, Richard G Carroll, et al.
Page
of 15